Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ: NVAX )

8.470 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
60 61 Next >
This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock?
Today, Novavax is getting ready to compete in the fall vaccine market -- one that's in transition. 
Via The Motley Fool
Novavax, Zscaler, Digital Brands Group, Asana, Tesla: Why These 5 Stocks Are Drawing Investor Attention Today
Via Benzinga
Why Novavax Stock Rocketed 10% Higher Today
The COVID vaccine maker benefits on a day when worries about a surge intensify with a new case at the White House. 
Via The Motley Fool
Exposures COVID-19
Why Novavax Stock Traded Higher Today
Novavax, Inc. (NASDAQ: NVAX) shares trader higher Tuesday amid rising COVID cases in the US, which has lifted vaccine stocks in recent weeks. 
Via Benzinga
Exposures COVID-19
Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?
Investors have worried about vaccine revenue in a post-pandemic world. 
Via The Motley Fool
Exposures COVID-19
2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with 
Via MarketBeat
Exposures COVID-19
Why Novavax (NVAX) Stock Is Rising
Novavax Inc (NASDAQ: NVAX) shares are trading higher by some 3.9% to $8.36 Monday morning. The stock is gaining amid rising COVID-19 cases in the U.S. 
Via Benzinga
Exposures COVID-19
Why Are Shares of Novavax Soaring Today?
The vaccine maker just gave investors some good news. 
Via The Motley Fool
7 Undervalued Stocks Due for a Massive Short Squeeze
These are the undervalued short squeeze candidates and these stocks represent fundamentally strong growth companies 
Via InvestorPlace
3 Biotech Stocks Due for a Massive Short Squeeze
These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters. 
Via InvestorPlace
Should You Buy Novavax's Stock Before the FDA Approves Its New COVID Shot?
The vaccine's approval could come within weeks. 
Via The Motley Fool
Exposures COVID-19 Product Safety
3 of Wall Street’s Most Shorted Stocks Due for a Massive Short Squeeze
These are the most shorted stocks trading in the U.S. stock market, and any good news could put their short sellers into a serious bind. 
Via InvestorPlace
Why Novavax Stock Was So Healthy on Monday
As the coronavirus threat rises, so too does the vaccine maker's value to investors. 
Via The Motley Fool
Exposures COVID-19
Why Is Novavax (NVAX) Stock Up 15% Today?
Investors in Novavax have had a very rough go over the past two years, but NVAX stock is rebounding nicely today. 
Via InvestorPlace
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02. 
Via Benzinga
Jabil, Boston Scientific, Hersha Hospitality Trust And Other Big Stocks Moving Higher On Monday
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
COVID Is Making a Comeback: Should You Buy These 2 Stocks?
Can these companies keep up their recent momentum? 
Via The Motley Fool
Exposures COVID-19
Are These 2 Companies Next for Short Squeezes?
Novavax and Seritage Growth Properties have unusually high short interest and potential short squeeze catalysts. 
Via The Motley Fool
7 Very Oversold Nasdaq Stocks to Buy Right Now
The worries that have pushed the Nasdaq down sharply are overdone. Here are seven oversold Nasdaq oversold Nasdaq investment opportunities. 
Via InvestorPlace
AMTD, VFS, NVAX, DKS, TSLA: Why These 5 Stocks Are Drawing Investor Attention Today
Via Benzinga
APP Stock Price Predictions: Is AppLovin Really Worth $50?
Applovin (APP) stock is in the news Tuesday after the stock got a new price target from Jefferies analyst Andrew Uerkwitz. 
Via InvestorPlace
Why Novavax Stock Is Trading Higher Tuesday
Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday after the company said its updated COVID-19 vaccine generated neutralizing antibody responses to the 
Via Benzinga
Exposures COVID-19
Why Is Fulcrum Therapeutics (FULC) Stock Up 43% Today?
Fulcrum Therapeutics (FULC) stock is on the rise Tuesday after the FDA removed a clinical hold on its sickle-cell disease candidate. 
Via InvestorPlace
Exposures Product Safety
Novavax (NVAX) Stock Is Getting Ready to Rally Again
Novavax only has an Emergency Use Authorization and faces a struggle to get paid for its protein-based Covid shot. 
Via InvestorPlace
Exposures COVID-19
Why Moderna, BioNTech SE, and Novavax Surged Today
The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign. 
Via The Motley Fool
Exposures COVID-19
Why Novavax Stock Is Trading Higher Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Monday amid a new COVID wave and rising hospitalizations. 
Via Benzinga
Exposures COVID-19
Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance
The companies are hoping to launch their updated Covid shots in September. 
Via Investor's Business Daily
Exposures COVID-19
Novavax Posted a Profit in Q2. Here's Why It Doesn't Matter
The stock's future remains hazy, at best. 
Via The Motley Fool
3 Biotech Stocks to Sell in August Before They Crash and Burn
These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late. 
Via InvestorPlace
Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.